Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders - Poll - MDSpire

Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders

  • By

  • Edward Koo

  • Sarah Albert

  • Benjamin Patrick

  • Meriem Henia

  • Yona Rhiwi

  • Christopher McCudden

  • Victor Jimenez Zepeda

  • Irwindeep Sandhu

  • Michael Chu

  • Hira Mian

  • Alissa Visram

  • March 26, 2026

  • 0 min

Share

Original Source(s)

Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders

  • by Edward Koo, Sarah Albert, Benjamin Patrick, Meriem Henia, Yona Rhiwi, Christopher McCudden, Victor Jimenez Zepeda, Irwindeep Sandhu, Michael Chu, Hira Mian, Alissa Visram

  • March 26, 2026

Related Content

Not all plasma cells are made equal: well-hidden layers of heterogeneity

Case Study: Non-secretory Multiple Myeloma with Eosinophilia - Diagnostic Hurdles and a Comprehensive Literature Review

CRISPR Enables In Vivo CAR T Cell Production

In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing

  • March 30, 2026

  • 2 min